Further experiments, therefore, are needed in order to test the in vitro sensitivity of synovial cells from TNF-blocking therapy-resistant patients to increasing concentrations of TNF-α-, IL-1β-, or IL-17-blocking agents and finally to identify the mechanisms of resistance to TNF blockade in RA. Here, IL17A is linked to rheumatoid arthritis.